Full-Time
Deputy Editor
Advanced Nanobiomed Research
John Wiley & Sons
51-200 employees
Publishes scientific, technical, and medical literature
Compensation Overview
$73.1k - $104.6k/yr
Union City, NJ, USA
In Person
 Journalism (1) |
|---|
- A PhD in Biomedical Engineering, Molecular Biology, or a related field with an excellent research background and a strong understanding of recent trends and developments.
- Subject matter expertise in all fields of biomedical engineering, biomaterials, nanomedicine, and therapeutics, and/or related fields.
- Strong teamwork and communication skills, with a flexible and innovative approach to problems and a focus on defining and achieving outcomes.
- Ability to work in a collaborative setting and achieve results through personal influence and engagement.
- A self-motivated, diplomatic, and flexible approach with outstanding organizational, efficiency, and time management skills and an excellent command of the English language (both written and verbal).
- A strong understanding of scientific publishing, including commissioning and the peer-review process. Prior experience in publishing, editorial, or science communication and understanding of Open Access workflows and Open Research is highly desirable.
- A keen interest in science and science communication, and a strong desire to advocate for innovations in publishing and open research.
- Confidence to present and represent the journal portfolio at conferences
- Strategically develop one or more journals, together with the Editor-in-Chief, from scientific and publishing perspectives within the context of the broader physical sciences journal portfolio.
- Establish and maintain a strong network of scientists who are the journals' authors, peer reviewers, and board members.
- Leverage your network, knowledge of the subject area and its development, and desk research skills to drive content acquisition and submissions growth.
- Represent Wiley and the physical sciences portfolio at conferences and through in-person and virtual outreach activities at universities and research institutes.
- Collaborate with colleagues across departments to develop the journal portfolio.
- Contribute to the editorial evaluation, peer review, and decision-making for manuscripts submitted to one or more journals.
- 2+ years of post-PhD work experience would be beneficial but not essential.
- Prior experience in publishing, editorial, or science communication and understanding of Open Access workflows and Open Research is highly desirable.
- Confidence to present and represent the journal portfolio at conferences
John Wiley & Sons publishes scholarly, professional, and educational content across science, technology, medicine, and the humanities. Its products include textbooks, journals, reference works, and digital resources delivered through the Wiley Online Library and other platforms. Wiley works with authors, editors, and peer reviewers to produce content, then distributes it via print, digital subscriptions, licensing, and open-access options to libraries, universities, researchers, and professionals. The company differentiates itself through a long history as a family-run business spanning six generations, a strategic shift from general printing to science and professional publishing, and a global scale as a publicly traded leader in educational and professional resources. Its goal is to provide reliable, accessible resources that support education, research, and professional development worldwide.
Company Size
51-200
Company Stage
IPO
Headquarters
Hoboken, New Jersey
Founded
1807
Simplify's Take
What believers are saying
- Jessica Kowalski from Microsoft leads research AI transformation effective May 11, 2026.
- AMNH partnership digitizes 120,000 mineral spectra for KnowItAll and SpectraBase in spring 2026.
- OpenEvidence integrates Wiley's Cochrane reviews and 400 journals for clinical AI on March 4, 2026.
What critics are saying
- Family holds 70% shares, 49% voting power, slows AI shifts versus OpenAI, Google Scholar.
- OpenEvidence partnership commoditizes content, erodes direct physician relationships within 18-36 months.
- SpectraBase open access cannibalizes premium KnowItAll subscriptions within 12-24 months.
What makes John Wiley & Sons unique
- Wiley pivoted from 19th-century literature to science publishing in late 1800s under William Wiley.
- Research Exchange platform adopted by Liverpool University Press on April 15, 2026, as first third-party.
- KnowItAll software powers spectral databases like Mass Spectra of Designer Drugs 2026 with 37,075 spectra.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at John Wiley & Sons who can refer or advise you
Benefits
Remote Work Options
Hybrid Work Options
Professional Development Budget
Company News
Placing a fractional leader at Wiley to deliver a brand strategy project. Naomi Hamilton Head of Interim and Talent Operations Our sister business, Growth Partners, are delighted to have partnered with the team at Wiley to source a Fractional Marketing leader. Wiley is a global leader in research and education that has helped learners and institutions achieve their goals for over 200 years. With a large portfolio covering scientific journals and professional development, Wiley is a vital part of the global knowledge economy. The organisation operates on a massive scale, supporting millions of researchers and students worldwide The challenge. As a long-standing business with a complex global presence, Wiley needed to align its brand strategy across different business units and international markets. The internal team required a senior leader who could navigate a large corporate structure to create a single, global brand strategy. The board recognised that they needed more than just a marketing specialist; they required a seasoned leader who could drive business value and profitability by aligning brand perception with the evolving digital landscape of professional publishing. The brief was to source a heavy-weight fractional expert who could provide immediate objectivity, serve as a 'CEO whisperer' to provide independent views, and translate complex brand concepts into tangible bottom-line growth. The solution. The team at Growth Partners worked closely with Wiley's senior leadership to understand the unique pressures facing their executive board. Using our network of pre-vetted fractional leaders, we identified a marketing consultant with the high-level stakeholder management skills required to navigate an enterprise of Wiley's scale. The fractional marketing leader led the brand evolution by bridging the gap between high-level ambition and operational execution. Their impact was focused across four key strategic areas: * Capability & Skill Gap Analysis: She conducted a strategic review of the existing brand team and its capabilities, advising the CMO on skill gaps and future opportunities to ensure the team was equipped for long-term success. * Global Brand Management & Agency Lead: She oversaw the global brand project in direct collaboration with Wiley's chosen agency, Design Bridge & Partners, ensuring the creative output met the strategic requirements of the brief. * Stakeholder Engagement & Buy-in: Leveraging deep experience in global markets, she engaged with senior stakeholders and the Executive Board to secure the necessary approvals and internal buy-in throughout the process. * Strategic Integration of EVP: Working closely with HR and People teams, she ensured the new brand framework was deeply integrated into the Employee Value Proposition (EVP) and company values to maximise the impact on internal culture. The appointed consultant provided the immediate objectivity and 'CEO whisperer' approach needed to deliver home truths and drive business growth. By focusing on business value rather than just tactical tasks, this placement ensured that Wiley's marketing efforts led to long-term commercial success About tml Partners: specialist headhunters for marketing and commercial roles. tml Partners are specialists in Executive Search with access to a global network of commercial, marketing, communications, brand, product and digital leaders. Our team work with businesses ranging from fast-growth challe nger brands to blue-chip organisations to develop their in-house tea ms. Our sister business, Growth Partners, specialises in Fractional Marketing, Sales, and Revenue Operations To learn how tml Partners can help you, please get in touch.
Wiley and American Museum of Natural History to digitize mineral collection into Raman spectral database. This partnership will digitize spectra from more than 120,000 mineral specimens, opening reference data to researchers across geology, forensics, materials science, and related fields. In a recent announcement, Wiley, a publishing and research intelligence company, and the American Museum of Natural History (AMNH) have to create a comprehensive Raman spectral database drawn from the Museum's mineral collection, which is one of the largest and most significant in the world. The first installment of data is expected to be available later this spring.[1] The partnership will produce spectroscopic reference data from the AMNH's holdings of more than 120,000 mineral specimens and 5,000 gems, which is a collection that has anchored geological research since the Museum's founding in 1869.[1] Wiley will distribute the resulting data sets through two platforms: its KnowItAll analytical chemistry software and SpectraBase, its publicly accessible online spectral database. Why does this partnership matter? This partnership matters because it is designed to result in greater access to authenticated mineral spectra. Spectral databases often function as, and researchers rely on these databases for their own projects.[2] Researchers working to identify unknown materials normally compare an unknown substance's spectral signature against authenticated reference standards to confirm composition. As a result, researchers rely on reference libraries to have quality spectra and an extensive database. In addition, access to authenticated mineral spectra has practical implications across a wide range of disciplines. Geologists and mineralogists use in both field and laboratory settings, while forensic scientists rely on similar techniques to analyze trace evidence. Archaeologists use mineral analysis to authenticate and, and materials scientists need reliable reference data when developing or testing new compounds.[1,3] The expanded database is also expected to support the development of machine learning (ML) algorithms and computational models for analyzing materials not yet formally characterized.[1] For many of these researchers, obtaining access to authenticated reference data from a collection of the AMNH's caliber has historically been limited. What is the scope of this project? Kate Kiseeva, curator in the Division of Physical Sciences and of the Mignone Halls of Gems and Minerals at the AMNH, noted that the scope of this collaboration extends the scientific utility of a collection built over more than 150 years. "Our mineral collection has been a cornerstone of geological research since the Museum's founding in 1869," Kiseeva said in a press release.[1] "This project with Wiley will greatly expand access to this valuable scientific collection in new ways, providing scientists worldwide with high-quality spectroscopic reference data that will advance mineral identification and analysis for years to come." According to Wiley, their dual-channel distribution model, through both its licensed KnowItAll platform and the openly accessible SpectraBase, is designed to reach both commercial and academic users. SpectraBase currently hosts hundreds of thousands of reference spectra across multiple analytical techniques, and the AMNH mineral data will be integrated incrementally, with additional records added following the initial spring release.[1] Graeme Whitley, senior director of data science solutions at Wiley, described the initiative as consistent with the company's broader effort to build shared scientific infrastructure. "The AMNH's minerals collection represents an extraordinary scientific resource," Whitley said in a statement,[1] "and by creating comprehensive spectral libraries, we're enabling researchers everywhere to leverage this knowledge in their work." What does this partnership mean for museum collections moving forward? This partnership shows that museums, such as AMNH, are looking to digitize its vast physical holdings in order to increase the scientific return on them. By digitizing the spectral data from these minerals, researchers who cannot visit the museum on-site will have access to them. What does this partnership mean for Wiley? For Wiley, the partnership extends a spectral database business that serves pharmaceutical, chemical, forensic and materials science sectors. The company has positioned reference data as a core component of its scientific infrastructure strategy alongside its traditional publishing and research analytics operations. References. Get essential updates on the latest spectroscopy technologies, regulatory standards, and best practices - subscribe today to Spectroscopy.
Wiley's Mass Spectra of Designer Drugs 2026 expands coverage of emerging novel psychoactive substances. New database release adds 700+ spectra and 400 compounds, helping forensic labs identify emerging designer drugs faster Wiley, a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today announced the 2026 release of Mass Spectra of Designer Drugs, the essential GC-MS spectral database used by forensic laboratories worldwide for the rapid identification of illicit substances. As the landscape of novel psychoactive substances (NPS) continues to evolve - with growing numbers of synthetic cannabinoids, metabolites, fentanyl analogs, pharmaceutical drugs and metabolites, derivatives, and other emerging compounds - laboratories rely on continuously updated reference data to keep pace. The latest release includes updates to ensure comprehensive and up-to-date support for forensic, toxicology, and drug surveillance workflows: * Addition of over 700 new mass spectra * More than 400 new unique compounds, spanning key NPS categories such as fentanyl variants, xylazine, synthetic opioids, including nitazene opioids, and cannabinoids * 37,075 total mass spectra and 27,900 unique chemical entities now represented in the database. "The 2026 release strengthens Wiley's position as the leading source of trusted spectral intelligence, giving laboratories the high-quality data they need to quickly and confidently identify emerging designer drugs with confidence," said Graeme Whitley, senior director of data science solutions at Wiley. "These enhancements directly support forensic and public health efforts as new harmful substances continue to appear." Purpose-Built for forensic and Analytical laboratories. Engineered for the unique demands of forensic and toxicology labs, the Mass Spectra of Designer Drugs database works with most major mass-spectrometry systems and is also available as a KnowItAll database subscription. When paired with Wiley's KnowItAll software, the database unlocks a powerful suite of advanced forensic tools, including drug classification models and Wiley's patented MS Adaptive Search, that accelerate the identification and interpretation of both known and emerging compounds. These capabilities empower analysts to detect even novel or unusual substances with greater speed, clarity, and certainty, reinforcing the database's role as an indispensable resource for laboratories working at the front lines of drug detection. * Inara Aguiar linkedin More by this author Inara is a science communicator with a Ph.D. in Inorganic Chemistry. After a postdoc in Computational Chemistry, she became a science editor specializing in Chemistry, Engineering, Bioengineering, and Biochemistry. With several years of experience in scientific writing and editing, she collaborates with Wiley Analytical Science, covering topics like microscopy and spectroscopy.
Wiley content to power OpenEvidence clinical AI platform. 4 March 2026 Wiley has announced a strategic partnership with medical AI platform OpenEvidence that will integrate a large portfolio of the publisher's peer-reviewed scientific and medical content into the platform used by physicians at the point of care. Through the partnership, clinicians using OpenEvidence will gain access to evidence drawn from hundreds of Wiley journals and reference works across a range of medical specialties to support clinical decision-making. The collaboration reflects growing interest across the healthcare and scholarly publishing sectors in ensuring that AI systems used in clinical settings are grounded in authoritative, peer-reviewed research rather than unverified web sources. Medical knowledge is estimated to double every 73 days, yet historically it has taken an average of 17 years for published research to be translated into clinical practice. OpenEvidence was designed to address this gap by training specialised AI models on peer-reviewed literature and ensuring that every response is linked to verifiable sources. Daniel Nadler, founder of OpenEvidence, said: "The hard problem in medicine right now isn't just generating new knowledge. We are living through a golden age of biomedical research. The hard problem is also that it takes 17 years for a fraction of that research to reach the bedside. Wiley is an ideal partner in solving this problem for physicians. The depth and breadth of Wiley's content reinforce the advantages of OpenEvidence for physicians, and that compounds over time." Under the agreement, Wiley will license a comprehensive portfolio of scientific and medical content to OpenEvidence. This includes the Cochrane Database of Systematic Reviews, widely regarded as a gold-standard source of evidence syntheses used to inform clinical guidelines worldwide, as well as Cochrane Clinical Answers, which provides curated clinical insights derived from Cochrane reviews. "Cochrane systematic reviews are relied upon by evidence users worldwide, from patients and healthcare professionals to guideline-setters and policymakers," said Karla Soares-Weiser, CEO of Cochrane. "AI is rapidly changing the ways that people use and access evidence, and we hope that this partnership helps to ensure that outputs from AI-powered tools are based on the best possible evidence." The licensed portfolio will also include more than 400 Wiley journals and books, alongside major reference works such as Holland-Frei Cancer Medicine, Rook's Dermatology Handbook, and Yamada's Textbook of Gastroenterology. These resources span multiple specialties including cardiology, endocrinology, geriatrics, hematology, internal medicine, neurology, obstetrics, oncology, psychiatry and rheumatology. According to the companies, the content will be incorporated into OpenEvidence's evidence layer and cited transparently within responses. The platform says it is already trusted by more than 40% of physicians in the United States. For clinicians, the partnership aims to expand access to reliable evidence directly within their clinical workflow. By broadening the available literature, the companies say the platform will help physicians address complex or unusual clinical questions without needing to leave the point-of-care environment. Matt Kissner, president and CEO of Wiley, concluded: "At the end of the day, we believe doctors will be able to make better decisions because we're bringing Wiley's vast portfolio of peer-reviewed scientific and medical content into OpenEvidence, where those decisions are getting made. We're excited about this partnership, which reflects our broader commitment to integrating trusted scientific knowledge into the technologies driving innovation across healthcare and life sciences."
News: academic publishing weekly. Publisher partnership expansions, new AI working group, and how to sustain diamond open access. Posted on February 20, 2026 in News Wiley and UC Press expand journal portfolios and partnerships. Wiley announced it is growing its Advanced Portfolio collection of scientific journals by another eight titles. Currently, the collection stands at 25 titles and the soon-to-be published journals will expand into the life, health, and social sciences disciplines. The publisher says the eight new journals will be launched by the end of the year, with more on the way. First to appear is Advanced Oncology, which will begin accepting submissions in March. The new journals will follow Wiley's existing editorial model, allowing authors to submit manuscripts once to the portfolio while the editors determine where to place them. "For more than 35 years, the Advanced brand has earned researchers' trust through rigorous standards and collaborative partnerships," said Allyn Molina, Wiley's group vice president of publishing development, in a statement. "Researchers have been telling us they need more prestigious yet accessible venues for their breakthrough work, and we listened; this expansion is our answer - launching premium options across every field of science." In other portfolio expansion news, the University of California Press (UC Press) has boosted its Journal Home presence in ResearchGate by another 15 titles after what it says was a successful five-journal pilot program. The program now includes the majority of UC Press's journal catalog and enhances brand visibility, content engagement, and author experience. "Our Journal Homes - including syndicated content and entitlement data - have enabled more meaningful interactions with our content, and have provided our journals with an expanded international reach. We look forward to growing our ResearchGate Journal Home partnership in 2026," said David Famiano, Journals Director, University of California Press, in a statement. New AI Working groups and standardizing agent development. Clarivate announced it is forming a second group of academic professionals to advise the company on its development of AI tools for research. Called the Academic AI Working Group, it will supplement Clarivate's existing Academia AI Advisory Council, which was formed in 2024. While the Council was created to offer higher-level conceptual guidance on academic AI trends, the Working Group will focus more on design and user experience issues, setting up complementary strategic and tactical insights straight from the field. Invitations to the new group are open until March 4, so sign up while you still can! Meanwhile, the National Institute of Standards and Technology (NIST) announced the launch of the AI Agent Standards Initiative, which aims to apply a framework of standards around the development of agentic AI. Since Choice360 can't have AI agents just running around like crazy little robots autonomously planning and coding things, the NIST, along with other federal agencies, will focus the Standards Initiative on three main areas: agent standards, open source protocol development and maintenance, and continued research around security and identity. Diamond OA "heroes" Need (financial) backing. Curt Rice, Executive Director of Fulbright Norway and Founder of Publishing Unlocked, reflects on the infrastructure of diamond open access for Scholarly Kitchen. Rice begins by comparing the early days of diamond OA - a tightknit community of researchers emailing or even (gasp!) physically mailing papers - to today's massive, amorphous, and extremely prolific publishing world to demonstrate that the desire to spread knowledge hasn't disappeared, but the scale has become too overwhelming to handle. In response, Rice urges stakeholders to invest in diamond OA as a viable infrastructure instead of a "collection of heroic individual efforts." Outlining what funders and institutions can do to support this venture, Rice notes that "the issue is not that diamond publishing depends on commitment; it is that the commitment is too often unsupported, unrecognized, and structurally fragile." STEM news: reaching sustainability and new database. It's STEM's week to shine. First, BioOne, a distribution platform for journals in the biological, ecological, and environmental sciences, has achieved its sustainability threshold for 2026. Due to support from more than 50 library partners and consortia, "the 2026 volumes of 71 titles within the BioOne Complete aggregation will be published Open Access, immediately and in perpetuity." BioOne follows the Subscribe to Open (S2O) model, joining organizations like Annual Reviews and Project Muse. Next, following updates to its Predatory Reports database earlier this month, Cabells rolled out Journalytics STEM, a database of journal data points dedicated to the STEM fields. Covering close to 8,000 journals across 26 subject areas, the database features journal information like submission rates, peer review times, Altmetric scores, and more. Who doesn't Love Book awards? The LA Times Book Prizes revealed the 2025 finalists and major category winners. Including genres like Biography, History, Poetry, Science & Technology, and more, the prizes "celebrate the best books of last year." The finalists include several university presses (Yale! MIT! North Carolina!); winners will be announced in mid-April. Next, Publishing Perspectives covered the shortlists for the Sheikh Zayed Book Award, which highlights "outstanding Arabic literature and transformative contributions to Arabic culture." Marking the 20th year of the award, this year's lists spotlight titles from New York University Press, American University of Beirut Press, and University of Pennsylvania Press, to name a few. Winners will be recognized in March. Independent Press Top 5 Bestsellers: Nonfiction The American Booksellers Association and the Independent Publishers Caucus recently collaborated on an independent bestsellers list, which includes books from independent presses and sold in indie bookshops. Below are the top five nonfiction titles this week. Find this week's full list of fiction and nonfiction independent bestsellers. 1. The Gales of November: The Untold Story of the Edmund Fitzgerald by John U. Bacon (Liveright) 2. Braiding Sweetgrass: Indigenous Wisdom, Scientific Knowledge, and the Teachings of Plants by Robin Wall Kimmerer (Milkweed Editions) 3. Mutual Aid: Building Solidarity During This Crisis (and the Next) by Dean Spade (Verso) 4. How to Love by Thich Nhat Hanh, Jason DeAntonis (Illus.) (Parallax Press) 5. Ursula K. Le Guin's Book of Cats by Ursula K. Le Guin (Library of America)